speb/financial-data huggingface dataset:
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 13993595000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 13993595000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 1299124.07
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Tax Provision: 625274000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 133300000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 112432000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 112432000.00
ALKYLAMINE.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -503077000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Total Assets: 17888578000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 17888578000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 14024844000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 14024844000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Total Debt: 55264000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 55264000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 14024844000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 14024844000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Total Expenses: 13217453000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 3358500000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 3863734000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3863734000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 11587415000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 11587415000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1412168000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1412168000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 4366000.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 5166000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
ALKYLAMINE.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 5166000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 8100000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 8100000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Work In Process: 86710000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 86710000.00
ALKYLAMINE.NS balance_sheet (annual, 2025-03-31) — Working Capital: 3849597000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 3849597000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1270100000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 4055300000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 51127198.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 9.67
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2198400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 178900000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 178900000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 51233161.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 9.65
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 494400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — EBIT: 666400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — EBITDA: 845300000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1856900000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 3000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 3000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Net Income: 494400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 494400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 494400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 494400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 494400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 494400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -3000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -3000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 845300000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 494400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Operating Income: 586800000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 4055300000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 79600000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 818200000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 663400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2198400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 178900000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 169000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 3468500000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1200300000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 3540000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 51162228.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 8.26
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1845000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 176900000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 176900000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 51224242.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 8.25
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 422600000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — EBIT: 574800000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — EBITDA: 751700000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1695000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 2400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Net Income: 422600000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 422600000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 422600000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 422600000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 422600000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 422600000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -2400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 751700000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 422600000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Operating Income: 494700000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 3540000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 80100000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 755800000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 572400000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1845000000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 176900000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 149800000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 3045300000.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — +Operating Expense: 4526542000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1245200000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — +Total Revenue: 15118846000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 3869100000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1512076000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1512076000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2296643000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2296643000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -3632112000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3632112000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 224951000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 224951000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Amortization: 4948000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 4948000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 240000000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 240000000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 51141556.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 51149944.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Basic EPS: 35.20
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 8.87
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 487787000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 1234364000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1234364000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1284037000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 11885000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 11885000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 102366000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 102366000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 941534000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 941534000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2509359000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2509359000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -511405000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 784000000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 784000000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 157534000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 157534000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 426501000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -341230000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 35604000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Change In Payable: -256802000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -3203000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -134099000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 453747000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Common Stock: 102366000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 102366000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 15333684000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 15333684000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 5671000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1304812000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1304812000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 8429690000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2095900000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Current Assets: 6727456000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 6727456000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 7973000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 7973000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Current Debt: 0.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 7973000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 7973000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 2158467000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2158467000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 22800000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 22800000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Depreciation: 711648000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 716596000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 716596000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 178900000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 711648000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 178900000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 51205895.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 51207675.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Diluted EPS: 35.15
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 8.86
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1799991000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 453700000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 13566000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 13566000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — EBIT: 2441666000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — EBIT: 610700000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — EBITDA: 3158262000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — EBITDA: 789600000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — End Cash Position: 941534000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -560802000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 544022000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 544022000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1101464000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -5896000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 1362000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 110339000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 29066000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 29066000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 2296643000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 2296643000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 15059092000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 15059092000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Gross Profit: 6689156000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1773200000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Interest Expense: 6994000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 2900000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 6994000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2900000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Interest Income: 157788000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 157788000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -10370000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 144801000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Inventories Adjustments Allowances: -6749000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -6749000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Inventory: 1221307000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1221307000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 15333684000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 15333684000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1370952000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 240000000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 240000000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 5671000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 312190000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 312190000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 3912000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3912000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3912000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3912000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 0.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -36045000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 141100000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 141100000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 11651951000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 11651951000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 5671000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 6786000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Net Income: 1799991000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Net Income: 453700000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1799991000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 453700000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1799991000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 453700000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1799991000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 453700000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1799991000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 453700000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2434672000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1799991000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 453700000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Net Interest Income: 146098000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -2900000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -500000000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -36045000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -36045000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 146098000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2900000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 263427000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Net PPE: 11426980000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 11426980000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1279180000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 15304618000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 15304618000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 324034000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 324034000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 992943000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 992943000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 141042000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 141042000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 133995000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 133995000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 3147244000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 789600000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Normalized Income: 1791845220.68
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 453700000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 2385501000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Operating Income: 2162614000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Operating Income: 528000000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Operating Revenue: 15118846000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 3869100000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 51144052.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 51144052.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 39435000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 39435000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 15849000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 15849000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 51900000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 51900000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 29066000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 29066000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 85884000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 85884000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -160961000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 27336000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 27336000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 1765000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 82700000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2145781000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 777500000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Payable: 441109000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 441109000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Properties: 555775000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 555775000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 128878000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 128878000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 1567825000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1567825000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Other Special Charges: -5122000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Payables: 1966751000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1966751000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 33760000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 33760000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 482365000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 482365000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Pretax Income: 2434672000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 607800000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -500000000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1284037000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 527185000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 527185000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 8429690000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2095900000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 716596000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 178900000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 3423000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 3423000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -36045000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 13567000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 13567000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 14583687000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 14583687000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 4857000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 557579000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 667918000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Share Issued: 51144052.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 51144052.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Special Income Charges: 5122000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 15802000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 15333684000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 15333684000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 15304618000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 15304618000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 2872220.68
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Tax Provision: 634681000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 154100000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.26
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 35902000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 35902000.00
ALKYLAMINE.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -476973000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Total Assets: 18954082000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 18954082000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 15333684000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 15333684000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Total Debt: 11885000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 11885000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 15333684000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 15333684000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Total Expenses: 12956232000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 3341100000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 3620398000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3620398000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 12226626000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 12226626000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1461931000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1461931000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 4696000.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 11018000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
ALKYLAMINE.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 11018000.00
ALKYLAMINE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Tradeand Other Payables Non Current: 9700000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 9700000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Work In Process: 70965000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 70965000.00
ALKYLAMINE.NS balance_sheet (annual, 2026-03-31) — Working Capital: 4568989000.00
ALKYLAMINE.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 4568989000.00
ALL cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
ALL cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: -218000000.00
ALL cash_flow (annual, 2021-12-31) — Dividend Received Cfo: 5112000000.00
ALL income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
ALL cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 321000000.00
ALL income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: -3593000000.00
ALL cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -436000000.00
ALL balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 833000000.00
ALL balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 833000000.00
ALL cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 66000000.00
ALL cash_flow (annual, 2021-12-31) — Other Non Cash Items: -4000000.00
ALL income_statement (annual, 2021-12-31) — Policyholder Benefits Ceded: 3569000000.00
ALL income_statement (annual, 2021-12-31) — Policyholder Benefits Gross: 33902000000.00
ALL income_statement (annual, 2022-12-31) — +Total Revenue: 50617000000.00
ALL balance_sheet (annual, 2022-12-31) — Accounts Receivable: 18784000000.00
ALL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3788000000.00
ALL income_statement (annual, 2022-12-31) — Amortization: 353000000.00
ALL income_statement (annual, 2022-12-31) — Basic Average Shares: 271200000.00
ALL income_statement (annual, 2022-12-31) — Basic EPS: -5.22
ALL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 763000000.00
ALL cash_flow (annual, 2022-12-31) — Capital Expenditure: -420000000.00
ALL balance_sheet (annual, 2022-12-31) — Capital Stock: 1979000000.00
ALL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 736000000.00
ALL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 4909000000.00
ALL cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -1031000000.00
ALL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -3420000000.00
ALL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1728000000.00
ALL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 5121000000.00
ALL cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -1256000000.00
ALL cash_flow (annual, 2022-12-31) — Change In Receivables: -587000000.00
ALL cash_flow (annual, 2022-12-31) — Change In Working Capital: 4428000000.00
ALL cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -587000000.00
ALL cash_flow (annual, 2022-12-31) — Changes In Cash: -27000000.00
ALL balance_sheet (annual, 2022-12-31) — Common Stock: 9000000.00
ALL cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -926000000.00
ALL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 15518000000.00
ALL cash_flow (annual, 2022-12-31) — Common Stock Payments: -2520000000.00
ALL balance_sheet (annual, 2022-12-31) — Current Debt: 1100000000.00
ALL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1100000000.00
ALL balance_sheet (annual, 2022-12-31) — Current Notes Payable: 1100000000.00
ALL cash_flow (annual, 2022-12-31) — Depreciation: 847000000.00
ALL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 847000000.00
ALL income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 353000000.00
ALL income_statement (annual, 2022-12-31) — Diluted Average Shares: 271200000.00
ALL income_statement (annual, 2022-12-31) — Diluted EPS: -5.22
ALL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -1394000000.00
ALL income_statement (annual, 2022-12-31) — EBIT: -1495000000.00
ALL cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 191000000.00
ALL cash_flow (annual, 2022-12-31) — End Cash Position: 736000000.00
ALL cash_flow (annual, 2022-12-31) — Financing Cash Flow: -3420000000.00
ALL balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -165000000.00
ALL cash_flow (annual, 2022-12-31) — Free Cash Flow: 4701000000.00
ALL cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 1755000000.00
ALL cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
ALL balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -2392000000.00
ALL income_statement (annual, 2022-12-31) — General And Administrative Expense: 116000000.00
ALL balance_sheet (annual, 2022-12-31) — Goodwill: 3502000000.00
ALL balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4679000000.00
ALL income_statement (annual, 2022-12-31) — Interest Expense: 335000000.00
ALL income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 335000000.00
ALL cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 323000000.00
ALL balance_sheet (annual, 2022-12-31) — Invested Capital: 23482000000.00
ALL cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1728000000.00
ALL balance_sheet (annual, 2022-12-31) — Investments And Advances: 59339000000.00
ALL balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 8114000000.00
ALL cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
ALL cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
ALL balance_sheet (annual, 2022-12-31) — Loans Receivable: 686000000.00
ALL balance_sheet (annual, 2022-12-31) — Long Term Debt: 6864000000.00
ALL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 6864000000.00
ALL cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
ALL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
ALL balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 8114000000.00
ALL income_statement (annual, 2022-12-31) — Loss Adjustment Expense: 38306000000.00
ALL balance_sheet (annual, 2022-12-31) — Minimum Pension Liabilities: 29000000.00
ALL balance_sheet (annual, 2022-12-31) — Minority Interest: -125000000.00
ALL income_statement (annual, 2022-12-31) — Minority Interests: 53000000.00
ALL cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -288000000.00
ALL cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -2520000000.00
ALL balance_sheet (annual, 2022-12-31) — Net Debt: 7228000000.00
ALL income_statement (annual, 2022-12-31) — Net Income: -1289000000.00
ALL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -1394000000.00
ALL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -1342000000.00
ALL income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
ALL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -1289000000.00
ALL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -1289000000.00
ALL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -1342000000.00
ALL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -1342000000.00
ALL income_statement (annual, 2022-12-31) — Net Interest Income: -335000000.00
ALL cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1288000000.00
ALL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
ALL income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -335000000.00
ALL cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 49000000.00
ALL balance_sheet (annual, 2022-12-31) — Net PPE: 987000000.00
ALL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -211000000.00
ALL income_statement (annual, 2022-12-31) — Net Policyholder Benefits And Claims: 38306000000.00
ALL cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
ALL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 12809000000.00
ALL income_statement (annual, 2022-12-31) — Normalized Income: -1251617000.00
ALL cash_flow (annual, 2022-12-31) — Operating Cash Flow: 5121000000.00
ALL cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2062000000.00
ALL income_statement (annual, 2022-12-31) — Operating Revenue: 50617000000.00
ALL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 263000000.00
ALL cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
ALL balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -2256000000.00
ALL income_statement (annual, 2022-12-31) — Other Income Expense: 2344000000.00
ALL balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1177000000.00
ALL income_statement (annual, 2022-12-31) — Other Operating Expenses: 7446000000.00
ALL balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 4173000000.00
ALL cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 116000000.00
ALL income_statement (annual, 2022-12-31) — Policyholder Benefits Ceded: 1628000000.00
ALL income_statement (annual, 2022-12-31) — Policyholder Benefits Gross: 39953000000.00
ALL balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 81000000.00
ALL balance_sheet (annual, 2022-12-31) — Preferred Stock: 1970000000.00
ALL cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -105000000.00
ALL income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 105000000.00
ALL balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 1970000000.00
ALL cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
ALL cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
ALL income_statement (annual, 2022-12-31) — Pretax Income: -1830000000.00
ALL cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 82000000.00
ALL cash_flow (annual, 2022-12-31) — Purchase Of Business: -1258000000.00
ALL cash_flow (annual, 2022-12-31) — Purchase Of Investment: -46509000000.00
ALL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -420000000.00
ALL balance_sheet (annual, 2022-12-31) — Receivables: 18784000000.00
ALL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 847000000.00
ALL cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
ALL cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -2520000000.00
ALL income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 51000000.00
ALL balance_sheet (annual, 2022-12-31) — Retained Earnings: 50970000000.00
ALL income_statement (annual, 2022-12-31) — Salaries And Wages: 116000000.00
ALL cash_flow (annual, 2022-12-31) — Sale Of Business: 970000000.00
ALL cash_flow (annual, 2022-12-31) — Sale Of Investment: 45221000000.00
ALL cash_flow (annual, 2022-12-31) — Sale Of PPE: 209000000.00
ALL income_statement (annual, 2022-12-31) — Selling General And Administration: 116000000.00
ALL balance_sheet (annual, 2022-12-31) — Share Issued: 900000000.00
ALL income_statement (annual, 2022-12-31) — Special Income Charges: -51000000.00
ALL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 17488000000.00
ALL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 10839000000.00
ALL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -13617000.00
ALL income_statement (annual, 2022-12-31) — Tax Provision: -488000000.00
ALL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.27
ALL balance_sheet (annual, 2022-12-31) — Total Assets: 97989000000.00
ALL balance_sheet (annual, 2022-12-31) — Total Capitalization: 24352000000.00
ALL balance_sheet (annual, 2022-12-31) — Total Debt: 7964000000.00
ALL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 17363000000.00
ALL income_statement (annual, 2022-12-31) — Total Expenses: 52447000000.00
ALL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 80626000000.00
ALL income_statement (annual, 2022-12-31) — Total Unusual Items: -51000000.00
ALL income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -51000000.00
ALL balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 637000000.00
ALL balance_sheet (annual, 2022-12-31) — Treasury Stock: 36857000000.00
ALL income_statement (annual, 2023-12-31) — +Total Revenue: 56591000000.00
ALL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 18853000000.00
ALL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 3854000000.00
ALL income_statement (annual, 2023-12-31) — Amortization: 329000000.00
ALL income_statement (annual, 2023-12-31) — Basic Average Shares: 262500000.00
ALL income_statement (annual, 2023-12-31) — Basic EPS: -1.20
ALL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 736000000.00